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Nd:YAG Laser Treatment of Early Stage Carcinoma 
of the Penis Preserves Form and Function of Penis
Mallika Tewari, Mohan Kumar1 and Hari S. Shukla, Departments of Surgical Oncology and 1Pathology, 
Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
INTRODUCTION: We analysed the results of penis-preserving (conservative) treatment of early stage
cancer of the penis with neodymium: yttrium-aluminium-garnet (Nd:YAG) laser with long-term follow-
up in a developing country.
METHODS: This was a retrospective study of 32 patients with cancer penis from 1993 to 2005 who were
treated by Nd:YAG laser local excision and in situ coagulation of the tumour bed.
RESULTS: Out of 32 patients who were treated with Nd:YAG laser, 25 had pT1 and seven had pT2 stage
cancer penis. The median follow-up was 70 months (range, 6–120 months). Two had stopped attending
the follow-up clinic after 6–12 months. Three patients had concurrent and six had delayed inguinal block
dissection. There was no mortality but two (6.25%) patients developed recurrence in 48–60 months post
laser excision. Penis was preserved in all 32 patients. All patients were satisfied with the cosmetic result.
Eight patients practiced celibacy, in 23 sexual functions were normal and in one this information was not
available. Micturition was in standing posture in all 32 patients.
CONCLUSION: The result of this study shows that Nd:YAG laser treatment of early stage cancer penis
has good local control with preservation of the penis. [Asian J Surg 2007;30(2):126–30]
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Introduction
Carcinoma of the penis is a rare disease (1–2/100,000
men)1 in the Western world but relatively common in
developing countries,2 occurring in men in the age group
of 40–70 years. Treatment of early stage penile carcinoma
is wide excision or partial penectomy with or without
inguinal lymph node dissection.3,4 Early disease (stage
I–II) is curable in most patients.5 A properly planned and
executed partial penectomy or wide excision is recurrence-
free, though there is marked emotional disturbance due
to loss of male sexuality.1 Laser ablation of the superficial
primary tumour has a prominent role as a penis-conserving
approach.6 There are random reports of penis-preserving
treatment with neodymium: yttrium-aluminium-garnet
(Nd:YAG) laser/carbon dioxide laser,7–24 though prospective
studies or guidelines to laser treatment are not mentioned.
We carried out local excision with a minimum of 3–5 mm
margin clearance and laser coagulation of the tumour bed
with Nd:YAG laser in a 54-year-old patient with pT2N0M0
stage cancer penis, who refused standard partial penec-
tomy in 1993. Since then, 31 more patients have been
treated with Nd:YAG laser. There was no randomization
and application of laser depended on its availability 
and the patient’s preference. We reviewed the treatment
of carcinoma penis by laser ablation and conventional
method and analysed the results retrospectively in this
study.
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Patients and methods
Between the year January 1993 and June 2005, all 106
patients with squamous cell carcinoma of the penis were
seen in the Department of Surgical Oncology at Institute
of Medical Sciences, Banaras Hindu University, Varanasi,
a tertiary care hospital in the northern part of India. In all
the patients, this was the first occasion in which the penis
was affected. None of the patients had a history of circum-
cision. All patients had a complete history and physical
examination when first seen. Full incision biopsy histology
was evaluated and histology done elsewhere was reviewed
by in-house pathologist to confirm the diagnosis. Race, eth-
nicity, clinical stage, pathological and operative data were
recorded. All patients had an ultrasound of the penile lesion
and groin along with cystourethroscopy in a selected few.
Patients with lesions on the prepuce or glans (<2 cm in
size) and refusing standard treatment were offered con-
servative laser excision. Informed consent was obtained.
In the rest, a standard surgical partial or total amputation
of the penis was done as appropriate. The patients were
restaged, retrospectively, according to the VIth edition of the
American Joint Committee on Cancer (AJCC) pathological
tumour-node-metastasis (pTNM) staging system.
Laser excision of penile cancer
Nd:YAG 100 watt equipment was used (Model Medilas-
2, MBB, Germany 1990). A contact sapphire probe was
used for contact laser excision and bare fibre for noncon-
tact in situ coagulation of the tumour bed till all the sus-
picious area was covered. All laser operations were done
under local anaesthesia administered by 0.5% lignocaine
infiltration.
The protocol for treatment was Nd:YAG laser sapphire
tip contact mode, circumcision with local excision of the
tumour from the penis cutting tangentially through glans/
corpora with a minimum of 3–5 mm margin and further
complete coagulation of the tumour bed with noncontact
mode laser irradiation to achieve uniform coagulation of
tissue for 3–4 mm. In general, the tissue defect was left
open for spontaneous healing by re-epithelialization from
the normal margins, which was usually completed in 7–9
weeks. If the excision involved or was close to the distal ure-
thra, the patient received an indwelling catheter for 1 week
postoperatively.
The treatment of the groin was independent of the type
of local treatment for carcinoma penis. A simultaneous
inguinal block dissection was done for fine needle aspiration
cytology positive inguinal nodes. A delayed full inguinal
block dissection was carried out if there was evidence 
of lymph node metastasis within 6–8 weeks or later in the 
follow-up.
In the post laser period, the laser treated area was
examined on day 1, day 4 and then twice weekly until
complete healing was achieved (Figures 1 and 2). After
6–8 weeks, the treated area was re-examined for healing
and evidence of residual disease in the form of ulcer or
nodular formations. A review at 3-monthly intervals was
carried out to examine wound healing, local recurrence
and urination. Enquiry was made regarding erectile and
sexual functions.
The follow-up examination data were updated from
the outpatient records. At the subsequent outpatient vis-
its, recurrence and survival information were updated.
The follow-up varied from 6 to 120 months, averaging 
70 months. Figure 3 shows the disease-free survival calcu-
lated with Kaplan–Meier curves.
Results
The frequency distribution of races and ethnicity indicated
that 100% of patients were Hindu. The socioeconomic
class listed was upper in five (15.6%), middle in 10 (31.3%)
and lower in 17 (53.1%) patients. Age of the patients was
32–67 years with a median of 47 years.
The histology was squamous cell carcinoma in all 
32 laser treated patients. The pTNM of the patients was
Figure 1. Perioperative photograph of a patient following 
conservative treatment of penile cancer with neodymium:
yttrium-aluminium-garnet laser showing the granulating wound.
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pT1 stage in 25 and pT2 in seven patients. Twenty-one
patients had grade 1, eight had grade 2 and three had
grade 3 cancer penis (Table). All 25 patients with pT1 stage
tumour had their tumour excised along with circumcision
with 3–5 mm margin. In the seven patients with pT2 stage
carcinoma, the lesion was also locally excised with 1/2–1 cm
healthy margin all around which included parts of the
glans and corpora cavernosa. The base of the excised area was
further irradiated to produce in situ coagulation with non-
contact mode of laser. There was no blood loss. Patients
stayed in the hospital for 1–5 days. None of the patients
required parenteral analgesics. There was no wound infec-
tion and antibiotics were administered in none. All 32 laser
treated patients with stage pT1 and pT2 disease had their
penis saved.
Patients conservatively treated with Nd:YAG laser 
were satisfied with the cosmetic appearance of the penis
(Figure 2). Micturition was in standing posture in all of
these 32 patients. Eight patients observed celibacy, in 23
sexual function was satisfactory and in one patient the
information could not be obtained.
There was no mortality in the laser treated group. Three
patients stopped attending the follow-up clinic after 
6 months to 1 year. One of these (pT2, N2, G3) returned after
4 years with widespread metastatic disease. This patient
had first refused any treatment but later agreed to undergo
conservative laser excision of his penile cancer, though 
he still refused an inguinal block dissection. One patient
BA
Figure 2. (A) Preoperative and (B) postoperative photograph of a patient following conservative treatment of penile cancer with
neodymium: yttrium-aluminium-garnet laser.
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Figure 3. Disease-free survival curve of 32 patients who under-
went conservative treatment of penile cancer with neodymium:
yttrium-aluminium-garnet laser, with a follow-up of 6–120 months.
Table. Distribution of pathological tumour stage, grade and ingui-
nal block dissection of the 32 patients treated with neodymium:
yttrium-aluminium-garnet laser
pT stage
Grade Inguinal block dissection
1 2 3 Concurrent Delayed
pT1 (25) 17 7 1 0 2
pT2 (7) 4 1 2 3 4
Total (32) 21 8 3 3 6
pT=pathological tumour stage (tumour-node-metastasis).
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(pT2, N1, G2) developed local recurrence after 60 months
that was salvaged by partial amputation of the penis.
Discussion
Treatment of T1 and T2 stage carcinoma penis is with wide
excision or partial penectomy with or without inguinal
lymph node dissection.3,4 A properly carried out partial
penectomy is curative. Early stage carcinoma may also be
treated by organ preserving methods—radiotherapy for
selected noninvasive small lesions,5,25 though radionecrosis
or stenosis of urethra makes the penis nonfunctional. How-
ever, at times, chordae and stricture urethra might also occur
after laser excision. Other organ preserving methods are pho-
todynamic therapy and Mohs’ micrographic surgery.26–28
Nd:YAG laser ablation of penile cancer is achieved with-
out loss of form or function of the penis with satisfactory
long-term results. Windahl et al7 noted unaltered erectile
function in 72%, decreased erection in 22% and improved
erection in 6% of the 40 patients sexually active before the
treatment, of whom 75% resumed their normal sex life
and 50% were satisfied with their sex life. In 78%, the self-
perceived cosmetic results were satisfactory.
The long-term results of laser treatment are comparable
to partial penectomy. Moreover, local recurrence following
laser ablation is salvaged by partial penectomy.12 The 5-year
survival benefit of conventional partial or total penectomy
in 150 patients was 83.3% for T1, 60.4% for T2 and 39.4% for
T3 cancers.29 None of the 32 patients treated conservatively
by laser have died of cancer. Two patients were lost to follow-
up. One developed local recurrence and one widespread
metastatic disease at 60 and 48 months, respectively, after
laser treatment.
Laser treatment of T1 and T2 stage carcinoma penis has
several advantages. During or post laser, there is no blood
loss, pain relief is achieved with oral analgesics, there is no
wound infection, and antibiotic administration is not
required. On long-term follow-up, cosmetic appearance of
the penis is unchanged or little altered and erectile func-
tion is retained. The patient is able to urinate in the normal
standing posture. Local treatment failure can be treated
with repeat laser application or partial/total penectomy.
The management of regional lymph nodes is on their own
merit, not affected by laser application. At this stage, a
prospective study of laser treatment for carcinoma of the
penis is required with a view to develop firm guidelines
for the application of laser to cancer of the penis.
References
1. Hadzi-Djokic J, Dzamic Z, Tulic C, et al. Surgical treatment and
quality of life in patients with carcinoma of the penis. Acta Chir
Iugosl 1999;46(Suppl 1):7–10.
2. Nagpal BL, Prabhakar BR, Kataria SP, et al. Male genital tract
tumours in Punjab, India. J Environ Pathol Toxicol Oncol 1992;
11:331–4.
3. Skinner DG, Leadbetter WF, Kelley SB. The surgical management
of squamous cell carcinoma of penis. J Urol 1972;107:273–7.
4. Persky L, Dekernion J. Carcinoma of the penis. CA Cancer J Clin
1986;36:258–73.
5. Mosconi AM, Roila F, Gatta G, Theodore C. Crit Rev Oncol Hematol
2005;53:165–77.
6. Kroon BK, Horenblas S, Nieweg OE. Contemporary manage-
ment of penile squamous cell carcinoma. J Surg Oncol 2005;89:
43–50.
7. Windahl T, Skeppner E, Andersson SO, Fugl-Meyer KS. Sexual
function and satisfaction in men after laser treatment for penile
carcinoma. J Urol 2004;172:648–51.
8. Opjordsmoen S, Waehre H, Aass N, Fossa SD. Sexuality in
patients treated for penile cancer: patients’ experience and 
doctors’ judgment. Br J Urol 1994;73:554–60.
9. Doehn C, Baumgartel M, Jocham D. Surgical therapy of penis
carcinoma. Urologe A 2001;40:303–7.
10. Babjuk M, Novak J, Dvoracek J. Nd:YAG laser in the treatment
of superficial lesions of the penis. Rozhl Chir 1998;77:497–9.
11. Blatstein LM, Finkelstein LH. Laser surgery for the treatment of
squamous cell carcinoma of the penis. J Am Osteopath Assoc 1990;
90:338–44.
12. Boon TA. Sapphire probe laser surgery for localized carcinoma
of the penis. Eur J Surg Oncol 1988;14:193–5.
13. Malloy TR, Wein AJ, Carpiniello VL. Carcinoma of penis treated
with neodymium YAG laser. Urology 1988;31:26–9.
14. Frimberger D, Schneede P, Hungerhuber E, et al. Autofluores-
cence and 5-aminolevulinic acid induced florescence diagnosis
of penile carcinoma—new techniques to monitor Nd:YAG laser
therapy. Urol Res 2002;30:295–300.
15. Kuzaka B, Szymanska K, Suleiman W. Nd:YAG laser cw in 
treatment of precancerous states of the penis. Pol Tyg Lek 1996;
51:98–9.
16. Weese D, Murphy J, Zimmern PE. Nd:YAG laser treatment of
extra mammary Paget’s disease of the penis and scrotum. J Urol
(Paris) 1993;99:269–71.
17. Malek RS. Laser treatment of premalignant and malignant 
squamous cell lesions of the penis. Lasers Surg Med 1992;12:
246–53.
18. Olsen PR, Lund F. Laser treatment of penile cancer. Ugeskr Laeger
1989;151:568–70.
19. Kvarstein B, Fossa SD, Harvei S. Diagnosis and treatment of
penile cancer. Tidsskr Nor Laegeforen 2002;122:1194–7.
20. Van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW.
Laser therapy for carcinoma in situ of the penis. J Urol 2001;166:
1670–1.
■ TEWARI et al ■
130 ASIAN JOURNAL OF SURGERY VOL 30 • NO 2 • APRIL 2007
21. Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia
and carcinoma of the penis. Urology 1998;52:559–65.
22. Clemente Ramos LM, Maganto Pavon E, Garcia Gonzalez R, 
et al. Verrucous carcinoma of the penis. A report of 6 new cases
and review of the diagnostic and therapeutic aspects. Actas Urol
Esp 1997;21:372–6.
23. Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date 
management of carcinoma of the penis. Eur Urol 1997;32:
5–15.
24. Windahl T, Hellsten S. Laser treatment of localized squamous
cell carcinoma of the penis. J Urol 1995;154:1020–3.
25. Fraley EE, Zhang G, Sazama R, Lange PH. Cancer of the penis:
prognosis and treatment plans. Cancer 1985;55:1618–24.
26. Singh I, Khaitan A. Current trends in the management of carci-
noma penis—a review. Int Urol Nephrol 2003;35:215–25.
27. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge
for the developing world. Lancet Oncol 2004;5:240–7.
28. Mohs FE, Snow SN, Messing EM, et al. Microscopically con-
trolled surgery in the treatment of carcinoma of the penis. J Urol
1985;133:961–6.
29. Kamat MR, Kulkarni JN, Tongaonkar HB. Carcinoma of the
penis: the Indian experience. J Surg Oncol 1993;52:50–5.
